Bob: "Adding 3-4 million shares to a 30 M o/s count is peanuts"
It is currently a little more than 30 million. The last count is over 42 M o/s and fully diluted, warrants and options of over 56 M. The dilutive factor is becoming significant and especially starting into therapeutics which will necessitate even a greater rate. I think they should have stuck to the plan of waiting for money from Abbott.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.